Editas Medicine (EDIT) Operating Margin (2016 - 2025)
Historic Operating Margin for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to 325.44%.
- Editas Medicine's Operating Margin rose 1073237400.0% to 325.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 428.71%, marking a year-over-year decrease of 586800.0%. This contributed to the annual value of 777.22% for FY2024, which is 5606700.0% down from last year.
- According to the latest figures from Q3 2025, Editas Medicine's Operating Margin is 325.44%, which was up 1073237400.0% from 1440.58% recorded in Q2 2025.
- Editas Medicine's Operating Margin's 5-year high stood at 39.9% during Q4 2023, with a 5-year trough of 136952.38% in Q3 2022.
- Moreover, its 5-year median value for Operating Margin was 940.09% (2023), whereas its average is 15270.04%.
- Per our database at Business Quant, Editas Medicine's Operating Margin plummeted by -1363189600bps in 2022 and then skyrocketed by 1360122900bps in 2023.
- Quarter analysis of 5 years shows Editas Medicine's Operating Margin stood at 333.71% in 2021, then tumbled by -191bps to 970.72% in 2022, then soared by 96bps to 39.9% in 2023, then tumbled by -282bps to 152.24% in 2024, then plummeted by -114bps to 325.44% in 2025.
- Its Operating Margin was 325.44% in Q3 2025, compared to 1440.58% in Q2 2025 and 1635.1% in Q1 2025.